Boston Scientific stories:
Dr. Donald Baim, 60, interventional cardiology pioneer
Nov 7th, 2009 - Boston
NATICK - Dr. Donald Baim, a renowned cardiologist and medical device executive, died yesterday following surgery to treat a form of cancer, his family said in a statement...
Donald Baim, Harvard professor and Boston Scientific executive, dies at 60
Nov 7th, 2009 - ChicagoTribune
NATICK, Mass (AP) - Dr. Donald Baim, a renowned cardiologist and medical device executive, died Friday following surgery to treat a form of cancer, his family said in a statement...
Cardiologist and Boston Sci exec Baim dies at 60
Nov 6th, 2009 - Boston
NATICK, Mass—Dr. Donald Baim, a renowned cardiologist and medical device executive, died Friday following surgery to treat a form of cancer, his family said in a statement...
Boston Scientific to Settle DOJ Defibrillator Case
Nov 6th, 2009 - Wall Street Journal
Boston Scientific Corp. will pay $296 million in an agreement with the Justice Department stemming from an investigation into problems with Guidant Corp. defibrillators and a major related recall in 2005.
Boston Scientific Pays $296 Million to Settle Probe
Nov 6th, 2009 - Bloomberg
Nov. 6 (Bloomberg) -- Boston Scientific Corp. agreed to pay$296 million to settle a U.S. Justice Department investigationinto the device maker’s Guidant subsidiary and restated third-quarter results to show a loss.
Boston Scientific videos from YouTube:
1:10Recall of Boston Scientific Vena Cava Filters (Feb. 2006)
Boston Scientific is recalling certain vena cava filter systems. The recalled devices are small cone-shaped filters used to help prevent pulmonary embolism. The filters are implanted in the ...
2:50Boston Scientific "kick off 2009"
LLEGADA HOTEL SHERATON BOSTON SCIENTIFIC CRE-ARTE
6:52Boston Scientific on Sustaining Every Day Innovation
In this video podcast, Kussman discusses Boston Scientific's definition of innovation and their bottom-up approach where everyone in the company is involved in the innovation process. He also ...
1:14
Boston Scientific from WikiPedia:
The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific is well known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. This product was at the center of a claim of patent infringement on the part of Boston Scientific, which was found liable for $431 million in damages.
Boston Scientific's main competitors are Johnson & Johnson, Medtronic, and St. Jude Medical. The company recently acquired longtime competitor Guidant for approximately $27 billion. The former Guidant was split between BSC and Abbott Laboratories.
Read more on WikiPedia
